{"text": "Today INOVIO announced interim Phase 1 data for INO-4800, our COVID-19 DNA vaccine candidate &amp; its selection in Operation Warp Speed. Learn more about the safety and preliminary response results, along with animal challenge data: https://t.co/OoMAHEYd7f #DNAMedicines #DNAVaccines https://t.co/bkdpfO7jtT", "entities": {"urls": [{"start": 234, "end": 257, "url": "https://t.co/OoMAHEYd7f", "expanded_url": "https://bit.ly/3eMpvQp", "display_url": "bit.ly/3eMpvQp"}, {"start": 285, "end": 308, "url": "https://t.co/bkdpfO7jtT", "expanded_url": "https://twitter.com/InovioPharma/status/1277929105476943872/photo/1", "display_url": "pic.twitter.com/bkdpfO7jtT"}], "hashtags": [{"start": 258, "end": 271, "tag": "DNAMedicines"}, {"start": 272, "end": 284, "tag": "DNAVaccines"}]}, "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "id": "1277929105476943872", "conversation_id": "1277929105476943872", "source": "Twitter Web App", "public_metrics": {"retweet_count": 109, "reply_count": 70, "like_count": 361, "quote_count": 53}, "created_at": "2020-06-30T11:36:56.000Z", "lang": "en", "possibly_sensitive": false, "attachments": {"media_keys": ["3_1277929092655046661"]}, "reply_settings": "everyone", "author_id": "613772062"}